SCHEMBL6982792

SCHEMBL6982792

CC(O)(c1cccc(-c2ccccc2)c1)c1cccc(-c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RXRA P19793 2/20 0.53
RXRB P28702 2/20 0.53
PTPN1 P18031 4/20 0.52
PTPN5 P54829 4/20 0.52
CYP17A1 P05093 1/20 0.50
CYP3A4 P08684 1/20 0.50
KIF11 P52732 1/20 0.50
MGLL Q99685 1/20 0.42
MAOA P21397 1/20 0.41
CNR1 P21554 1/20 0.41
CNR2 P34972 1/20 0.41
KMO O15229 1/20 0.41
CYP2C9 P11712 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
ALOX5 P09917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL548430 0.87 RXRA (0.53) RXRARXRBPTPN1PTPN5CYP17A1
SCHEMBL9782559 0.85 RXRA (0.42) RXRARXRBPTPN1PTPN5CYP17A1
SCHEMBL11432364 0.84 KMT2A (0.46) CYP3A4CYP2C9HDAC4HDAC2HDAC8
SCHEMBL27544292 0.83 KIF11 (0.50) RXRARXRBPTPN1PTPN5CYP17A1
SCHEMBL18639619 0.82 CYP2C9 (0.54) RXRARXRBPTPN5CYP17A1CYP3A4
SCHEMBL779683 0.82 KIF11 (0.70) RXRARXRBPTPN1PTPN5CYP17A1
SCHEMBL3681495 0.82 KIF11 (0.53) RXRARXRBPTPN1PTPN5CYP17A1
SCHEMBL20194757 0.81 RXRA (0.53) RXRARXRBCYP3A4CNR2KMO
SCHEMBL7855780 0.80 RXRA (0.56) RXRARXRBPTPN1PTPN5CYP17A1
SCHEMBL28423705 0.80 CNR1 (0.53) RXRARXRBPTPN1PTPN5CYP17A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1299379-A2 LACTAM METALLOPROTEASE INHIBITORS Bristol-Myers Squibb Pharma Company (US) 2003-04-09 EP disclosed
WO-2002004416-A2 LACTAM METALLOPROTEASE INHIBITORS BRISTOL-MYERS SQUIBB PHARMA COMPANY (US) 2002-01-17 WO disclosed
EP-1054877-A1 NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS Du Pont Pharmaceuticals Company (US) 2000-11-29 EP disclosed
WO-1999041246-A1 NOVEL CYCLIC SULFONAMIDE DERIVATIVES AS METALLOPROTEINASE INHIBITORS DU PONT PHARMACEUTICALS COMPANY (US) 1999-08-19 WO disclosed